Literature DB >> 30689883

Quantitative reduction of RyR1 protein caused by a single-allele frameshift mutation in RYR1 ex36 impairs the strength of adult skeletal muscle fibres.

Moran Elbaz1, Alexis Ruiz1, Jan Eckhardt1, Pawel Pelczar2, Francesco Muntoni3,4, Simona Boncompagni5, Susan Treves1,6, Francesco Zorzato1,6.   

Abstract

Here we characterized a mouse model knocked-in for a frameshift mutation in RYR1 exon 36 (p.Gln1970fsX16) that is isogenic to that identified in one parent of a severely affected patient with recessively inherited multiminicore disease. This individual carrying the RYR1 frameshifting mutation complained of mild muscle weakness and fatigability. Analysis of the RyR1 protein content in a muscle biopsy from this individual showed a content of only 20% of that present in a control individual. The biochemical and physiological characteristics of skeletal muscles from RyR1Q1970fsX16 heterozygous mice recapitulates that of the heterozygous parent. RyR1 protein content in the muscles of mutant mice reached 38% and 58% of that present in total muscle homogenates of fast and slow muscles from wild-type (WT) littermates. The decrease of RyR1 protein content in total homogenates is not accompanied by a decrease of Cav1.1 content, whereby the Cav1.1/RyR1 stoichiometry ratio in skeletal muscles from RyR1Q1970fsX16 heterozygous mice is lower compared to that from WT mice. Electron microscopy (EM) revealed a 36% reduction in the number/area of calcium release units accompanied by a 2.5-fold increase of dyads (triads that have lost one junctional sarcoplasmic reticulum element); both results suggest a reduction of the RyR1 arrays. Compared to WT, muscle strength and depolarization-induced calcium transients in RyR1Q1970fsX16 heterozygous mice muscles were decreased by 20% and 15%, respectively. The RyR1Q1970fsX16 mouse model provides mechanistic insight concerning the phenotype of the parent carrying the RYR1 ex36 mutation and suggests that in skeletal muscle fibres there is a functional reserve of RyR1.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30689883     DOI: 10.1093/hmg/ddz025

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  3 in total

Review 1.  Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.

Authors:  Tokunbor A Lawal; Emily S Wires; Nancy L Terry; James J Dowling; Joshua J Todd
Journal:  Orphanet J Rare Dis       Date:  2020-05-07       Impact factor: 4.123

2.  Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study.

Authors:  Aurora Fusto; Denise Cassandrini; Claudio Bruno; Elena Pegoraro; Chiara Fiorillo; Valentina Codemo; Guja Astrea; Adele D'Amico; Lorenzo Maggi; Francesca Magri; Marika Pane; Giorgio Tasca; Daniele Sabbatini; Luca Bello; Roberta Battini; Pia Bernasconi; Fabiana Fattori; Enrico Silvio Bertini; Giacomo Comi; Sonia Messina; Tiziana Mongini; Isabella Moroni; Chiara Panicucci; Angela Berardinelli; Alice Donati; Vincenzo Nigro; Antonella Pini; Melania Giannotta; Claudia Dosi; Enzo Ricci; Eugenio Mercuri; Giovanni Minervini; Silvio Tosatto; Filippo Santorelli
Journal:  Acta Neuropathol Commun       Date:  2022-04-15       Impact factor: 7.578

3.  In vivo RyR1 reduction in muscle triggers a core-like myopathy.

Authors:  Laurent Pelletier; Anne Petiot; Julie Brocard; Benoit Giannesini; Diane Giovannini; Colline Sanchez; Lauriane Travard; Mathilde Chivet; Mathilde Beaufils; Candice Kutchukian; David Bendahan; Daniel Metzger; Clara Franzini Armstrong; Norma B Romero; John Rendu; Vincent Jacquemond; Julien Fauré; Isabelle Marty
Journal:  Acta Neuropathol Commun       Date:  2020-11-11       Impact factor: 7.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.